RxDoctor Payments Data

Katharine Wetherbee, DO

Family Medicine · Londonderry, NHNPI 1366684755

Payments from drug & device makers

$573in general payments, 2019–2025

Across 23 payments — averaging $24.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Welch Allyn$149
  • Boehringer Ingelheim$82
  • AbbVie$73
  • Lilly USA, LLC$43
  • Pfizer$37
  • Inspire Medical Systems, Inc.$29
  • plus $159 from 8 others

What the payments were for

  • Food & beverage$42374%
  • Gifts$14926%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$573 in reported general payments places this provider in the 75th percentile of 397 family medicine providers in New Hampshire.

See all family medicine providers in New Hampshire

Medicare billing

Part B allowed, 2024
$149,644
Medicare patients
348
Services billed
2,023

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$36,054
OzempicSemaglutide14$28,557
Rosuvastatin Calcium88$1,887
Atorvastatin Calcium190$1,832
Metoprolol Succinate108$1,766
Gabapentin83$1,454
Fluoxetine Hcl27$1,451
SynthroidLevothyroxine Sodium30$1,415
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,107
Levothyroxine Sodium131$920
FenofibrateFenofibrate Nanocrystallized13$864
Losartan Potassium131$837
Lisinopril102$824
Oxycodone Hcl31$824
Pantoprazole Sodium70$819

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$36,05422 claims
Novo NordiskOzempic$15$28,55714 claims
AbbVieSynthroid$73$1,41530 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 397 family medicine providers in New Hampshire.

Other family medicine in Londonderry

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →